Neogen Chemicals Ltd Stock Price Today (NSE: NEOGEN)
Fundamental Score
Neogen Chemicals Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Neogen Chemicals Ltd share price today is ₹1330.90, up +0.00% on NSE/BSE as of 18 February 2026. Neogen Chemicals Ltd (NEOGEN) is a Small-cap company in the Specialty Chemicals sector with a market capitalisation of ₹2.98K (Cr). The 52-week high for NEOGEN share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 90.84x, NEOGEN is currently trading above its industry average P/E of 29.20x. The company has a Return on Equity (ROE) of 5.59% and a debt-to-equity ratio of 1.41.
Neogen Chemicals Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Neogen Chemicals Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Neogen Chemicals Share Price: A ROCE-Focused Analysis
The specialty chemicals sector, known for its customized solutions and niche applications, often commands premium valuations. However, sustaining these valuations requires superior operational efficiency and robust returns on capital. This analysis examines the current standing of Neogen Chemicals share price (₹1353.5) through the lens of Return on Capital Employed (ROCE), a critical metric for evaluating long-term value creation. The company's current PE ratio stands at a high 90.84, necessitating a closer look at its ability to justify this multiple through efficient capital allocation.
Neogen Chemicals Ltd. currently exhibits a ROCE of 8.82%. While positive, this figure warrants careful consideration, especially when benchmarked against industry expectations implied by its PE ratio. A higher ROCE generally indicates superior efficiency in generating profits from invested capital, suggesting a stronger competitive advantage. Conversely, a lower ROCE relative to peers could signal challenges in operational execution or pricing power. The magnitude of ROCE directly influences a company’s ability to reinvest profits effectively, impacting long-term growth and shareholder value.
The moat, or competitive advantage, of Neogen Chemicals is intrinsically linked to its ROCE. An 8.82% ROCE suggests a moderate level of capital efficiency. However, compared to sector peers like Amal, Bhatia Colour, and Deep Polymers, a comparative analysis of ROCE and management quality is crucial.
Amal, for instance, might boast a higher ROCE due to superior management execution or a more focused product portfolio. Understanding the drivers behind these differences is key to assessing Neogen’s long-term sustainable advantage. A higher ROCE allows for greater reinvestment in research and development, marketing, or capacity expansion, further strengthening the company's competitive positioning.Ultimately, the sustainability of Neogen Chemicals share price hinges on its ability to improve its ROCE. While the current market valuation reflects growth expectations, the company needs to demonstrate consistent improvement in capital efficiency to justify its premium PE ratio. This analysis, as part of a comprehensive 80-parameter fundamental audit verified by Sweta Mishra, offers an observational perspective on Neogen Chemicals' ROCE efficiency and its potential impact on long-term shareholder value. Further investigation into the company's operational strategies and capital allocation decisions is warranted to determine its ability to enhance its financial performance and bolster its competitive moat.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Neogen Chemicals Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of NEOGEN across key market metrics for learning purposes.
Positive Indicators
5 factors identified
Strong Operating Margins (17.09%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Consistent Growth Track Record (20.49% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Balanced Promoter Holding (51.23%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Strong Institutional Confidence (FII+DII: 30.37%)
Observation: Significant professional investor participation.
Analysis: High institutional holding often signals thorough due diligence.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
7 factors identified
Below-Average Return on Equity (5.59%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (8.82%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Premium Valuation Risk (P/E: 90.84x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-69.25%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Elevated Debt Levels (D/E: 1.41)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.
Weak Interest Coverage (1.90x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-703.28 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Neogen Chemicals Ltd Financial Statements
Comprehensive financial data for Neogen Chemicals Ltd including income statement, balance sheet and cash flow
About NEOGEN (Neogen Chemicals Ltd)
Neogen Chemicals Ltd (NEOGEN) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Specialty Chemicals sector with a current market capitalisation of ₹2.98K (Cr). Neogen Chemicals Ltd has delivered a Return on Equity (ROE) of 5.59% and a ROCE of 8.82%. The debt-to-equity ratio stands at 1.41, reflecting the company's capital structure. Investors tracking NEOGEN share price can monitor key metrics including P/E ratio, promoter holding of 51.23%, and quarterly earnings growth.
Company Details
Key Leadership
NEOGEN Share Price: Frequently Asked Questions
What is the current share price of Neogen Chemicals Ltd (NEOGEN)?
As of 18 Feb 2026, 05:12 am IST, Neogen Chemicals Ltd share price is ₹1330.90. The NEOGEN stock has a market capitalisation of ₹2.98K (Cr) on NSE/BSE.
Is NEOGEN share price Overvalued or Undervalued?
NEOGEN share price is currently trading at a P/E ratio of 90.84x, compared to the industry average of 29.20x. Based on this relative valuation, the Neogen Chemicals Ltd stock appears to be Overvalued against its sector peers.
What is the 52-week high and low of NEOGEN share price?
The 52-week high of NEOGEN share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Neogen Chemicals Ltd share price?
Key factors influencing NEOGEN share price include quarterly earnings growth (Sales Growth: 7.91%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Neogen Chemicals Ltd a good stock for long-term investment?
Neogen Chemicals Ltd shows a 5-year Profit Growth of 8.61% and an ROE of 5.59%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 1.41 before investing in NEOGEN shares.
How does Neogen Chemicals Ltd compare with its industry peers?
Neogen Chemicals Ltd competes with major peers in the Specialty Chemicals. Investors should compare NEOGEN share price P/E of 90.84x and ROE of 5.59% against the industry averages to determine competitive standing.
What is the P/E ratio of NEOGEN and what does it mean?
NEOGEN share price has a P/E ratio of 90.84x compared to the industry average of 29.20x. Investors pay ₹91 for every ₹1 of annual earnings.
How is NEOGEN performing according to Bull Run's analysis?
NEOGEN has a Bull Run fundamental score of 27.3/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does NEOGEN belong to?
NEOGEN operates in the Specialty Chemicals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Neogen Chemicals Ltd share price.
What is Return on Equity (ROE) and why is it important for NEOGEN?
NEOGEN has an ROE of 5.59%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Neogen Chemicals Ltd generates profits from shareholders capital.
How is NEOGEN debt-to-equity ratio and what does it indicate?
NEOGEN has a debt-to-equity ratio of 1.41, which indicates high leverage that increases financial risk.
What is NEOGEN dividend yield and is it a good dividend stock?
NEOGEN offers a dividend yield of 0.09%, meaning you receive ₹0.09 annual dividend for every ₹100 invested in Neogen Chemicals Ltd shares.
How has NEOGEN share price grown over the past 5 years?
NEOGEN has achieved 5-year growth rates of: Sales Growth 20.49%, Profit Growth 8.61%, and EPS Growth 5.98%.
What is the promoter holding in NEOGEN and why does it matter?
Promoters hold 51.23% of NEOGEN shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Neogen Chemicals Ltd.
What is NEOGEN market capitalisation category?
NEOGEN has a market capitalisation of ₹2984 crores, placing it in the Small-cap category.
How volatile is NEOGEN stock?
NEOGEN has a beta of N/A. A beta > 1 suggests the Neogen Chemicals Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is NEOGEN operating profit margin trend?
NEOGEN has a 5-year average Operating Profit Margin (OPM) of 17.09%, indicating the company's operational efficiency.
How is NEOGEN quarterly performance?
Recent quarterly performance shows Neogen Chemicals Ltd YoY Sales Growth of 7.91% and YoY Profit Growth of -69.25%.
What is the institutional holding pattern in NEOGEN?
NEOGEN has FII holding of 5.15% and DII holding of 25.22%. Significant institutional holding often suggests professional confidence in the Neogen Chemicals Ltd stock.